Trials / Unknown
UnknownNCT02715648
Using Phenazopyridine for In-office Cystoscopy
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 94 (estimated)
- Sponsor
- Boston Urogynecology Associates · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The investigators propose to conduct a randomized controlled trial to evaluate whether administration of phenazopyridine prior to the procedure decreases office cystoscopy time. Women undergoing in-office cystoscopy at Boston Urogynecology will be recruited.
Detailed description
All potentially eligible participants will have had a complete history, physical examination, urinalysis and urine culture for clinical purposes. After eligibility is confirmed and written, informed consent is obtained, participants will be randomized to one of the two study arms. Participants randomized to phenazopyridine arm will receive 200 mg by mouth approximately 60 minutes prior to the scheduled cystoscopy. During the cystoscopy, at various time points, the time will be recorded.The color of the efflux will also be documented.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Phenazopyridine |
Timeline
- Start date
- 2016-04-01
- Primary completion
- 2021-06-01
- Completion
- 2021-06-01
- First posted
- 2016-03-22
- Last updated
- 2020-12-31
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02715648. Inclusion in this directory is not an endorsement.